15-62675229-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_015059.3(TLN2):āc.865T>Cā(p.Cys289Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,614,102 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 33)
Exomes š: 0.00027 ( 3 hom. )
Consequence
TLN2
NM_015059.3 missense
NM_015059.3 missense
Scores
5
10
3
Clinical Significance
Conservation
PhyloP100: 7.99
Genes affected
TLN2 (HGNC:15447): (talin 2) This gene encodes a protein related to talin 1, a cytoskeletal protein that plays a significant role in the assembly of actin filaments and in spreading and migration of various cell types, including fibroblasts and osteoclasts. This protein has a different pattern of expression compared to talin 1 but, like talin 1, is thought to associate with unique transmembrane receptors to form novel linkages between extracellular matrices and the actin cytoskeleton. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 20 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLN2 | NM_015059.3 | c.865T>C | p.Cys289Arg | missense_variant | 11/59 | ENST00000636159.2 | NP_055874.2 | |
LOC105370855 | XR_007064673.1 | n.530-6157A>G | intron_variant, non_coding_transcript_variant | |||||
TLN2 | NM_001394547.1 | c.865T>C | p.Cys289Arg | missense_variant | 10/58 | NP_001381476.1 | ||
LOC105370855 | XR_007064672.1 | n.461-6157A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLN2 | ENST00000636159.2 | c.865T>C | p.Cys289Arg | missense_variant | 11/59 | 5 | NM_015059.3 | ENSP00000490662 | P1 | |
TLN2 | ENST00000561311.5 | c.865T>C | p.Cys289Arg | missense_variant | 10/58 | 5 | ENSP00000453508 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152228Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
20
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000274 AC: 69AN: 251448Hom.: 0 AF XY: 0.000346 AC XY: 47AN XY: 135902
GnomAD3 exomes
AF:
AC:
69
AN:
251448
Hom.:
AF XY:
AC XY:
47
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000271 AC: 396AN: 1461874Hom.: 3 Cov.: 36 AF XY: 0.000311 AC XY: 226AN XY: 727238
GnomAD4 exome
AF:
AC:
396
AN:
1461874
Hom.:
Cov.:
36
AF XY:
AC XY:
226
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74366
GnomAD4 genome
AF:
AC:
20
AN:
152228
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
38
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2024 | The c.865T>C (p.C289R) alteration is located in exon 8 (coding exon 8) of the TLN2 gene. This alteration results from a T to C substitution at nucleotide position 865, causing the cysteine (C) at amino acid position 289 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at